With the abundance of new practice-changing data, it is challenging for OSU and community oncology physicians and allied healthcare providers to stay up to date in the management of GI oncology patients and to implement these changes in clinical practice to improve patient care. Treatment options and clinical guidelines are modified year-round at specialty conferences and by national committees. This GI Oncology Symposium will provide a forum to summarize the key takeaways from other conferences and ensure physicians and providers are equipped to provide optimal care for their patients.
This symposium incorporates all the main specialties involved in GI oncology cancer care: surgical oncology, medical oncology, radiation oncology, interventional radiology, nuclear medicine experts, clinical nurse specialists and gastroenterology. During the tumor boards at the end of each session, we will highlight how other specialties can play an important role in their patients' care.
For pricing information, see pricing tab below.
Dates and Times
Start: 2/23/2024 7:00 AM
End: 2/23/2024 3:45 PM
At the conclusion of this activity, learners will be able to:
1. Employ the knowledge gained regarding the diagnosis and treatment of GI tumors to improve patient care.
2. Discuss and implement new systemic therapy options for GI cancers to improve patient care.
3. Discuss and implement new radiation therapy options for GI cancers to improve patient care.
4. Discuss and implement new surgical options for GI cancers to improve patient care.
5. Recognize when to use new diagnostic and response monitoring options for cancer therapy.
6. Be more aware of the contribution of multidisciplinary team members and know when to refer to other specialties.
7. Become familiar with the unique role and contribution of other health professionals in the care of GI oncology patients.
7:15 a.m. Registration and Continental Breakfast
8:00 a.m. Welcome
8:10a.m. SESSION 1: Introduction to Rare GI Cancers - John Hays, MD, PhD
8:15 a.m. Small Bowel Adenocarcinoma - Arjun Mittra, MD
8:35 a.m. Appendiceal Cancer - Alex Kim, MD, PhD
8:55 a.m. Ampullary Cancer - Susan Tsai, MD
9:15 a.m. Gallbladder Cancer
9:35 a.m. Tumor Board - John Hays, MD, PhD
9:55 a.m. BREAK (10 min)
10:05 a.m. SESSION 2: Gastroenteropancreatic Neuroendocrine Tumors - Jordan Cloyd, MD
10:10 a.m. Surgical Management of GI Neuroendocrine Tumors - Mary Dillhoff, MD
10:20 a.m. Systemic Therapy Options for Neuroendocrine Tumors - Bhavana Konda, MD, MPH
10:40 a.m. Radiopharmaceutical Diagnostics and Therapeutics - Emmanuel Appiah-Kubi, MD
11:00 a.m. Genetics of GI Neuroendocrine Tumors and Inherited Syndromes - Pamela Brock, MS, CGC
11:20 a.m. Tumor Board - Jordan Cloyd, MD
11:40 a.m. LUNCH (45 min)
12:25 p.m. SESSION 3: Colorectal Session - Alan Harzman, MD
12:30 p.m. Total Neoadjuvant Therapy in the Era of PROSPECT - Eric Miller, MD, PhD
12:50 p.m. Minimally Invasive Management of Colon & Rectal Cancer - Emily Huang, MD
1:10 p.m. Role of ctDNA in the Management of Colorectal Cancer - Ning Jin, MD
1:20 p.m. Wound and Ostomy Care - Jennifer Postle Huffman
1:40 p.m. Tumor Board - Alan Harzman, MD
2:00 p.m. BREAK (10 min)
2:10 p.m. SESSION 4: Management of Primary Liver Cancers - Ashish Manne, MBBS
2:15 p.m. Systemic Therapy Options for Hepatocellular Carcinoma and Cholangiocarcinoma - Ann Noonan, MBBCh, PhD
2:35 p.m. Updates on Liver Transplant Options for Primary Liver Cancers - Ashley Limkemann, MD, MPH
2:55 p.m. Radiation Therapy Options for Primary Livers Cancers - Kenneth Pitter, MD, PhD
3:15 p.m. Tumor Board - Ashish Manne, MBBS
3:35 p.m. Closing remarks and Evaluations
|Non-OSU MD, DO and PhD||$75.00|
|Clinicians, researchers and scientists (non-OSU)||$50.00|
|Non-GI OSU Faculty & Staff||$50.00|
|OSU GI Faculty & Staff||$0.00|
|OSU APPs and APP Fellows||$0.00|
|All other professionals||$100.00|
The Grand Event Center
820 Goodale Blvd
Grandview Heights, OH 43212
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.